Saturday, 14 November 2015

Drug Safety Associate - Voice Process - Night Shift Synowledge PV Services India Pvt Ltd

Synowledge PV Services India Pvt Ltd Careers
JOB TITLE: Drug Safety Associate

LOCATION: Mysore, India

YEARS OF EXPERIENCE: 0 to 1 years

EDUCATION: Health care professional (BPharm / B Sc nursing/ BDS/ MPharma/ Pharm D) OR PostGrads in Biotechnology, Microbiology, Biochemistry,Clinical Research, Bio-Physics, Molecular Biology, Medicinal Chemistry,Nuclear Sciences, Bioinformatics

ESSENTIAL DUTIES AND RESPONSIBILITIES:
As Case Intake Member:
Responsible for case intake, duplicate check , and registration
Maintain log of source documents and other communications

As Case Processor:
Responsible for data entry of individual case safety reports into the safety database.
Review and evaluate AE case information to determine required action based on and following internal policies and procedures
Process all incoming cases in order to meet timelines
Full data entry including medical coding and safety narrative

As Medical Coder
Responsible for coding all medical history, events, drugs /procedures/indications and laboratory tests according to the appropriate dictionary (For e.g. MedDRA, Company Product Dictionary, WHO-DD)

As Narrative Writer
Responsible for writing medically relevant safety narrative of cases and checking the completeness and accuracy of the data entered in the various fields.

As Literature Review Specialist
Ensure effective and accurate collection, recording, review and reporting of literature searches conducted.
Review of literature articles to identify case safety reports.
Responsible for operational Pharmacovigilance activities for assigned developmental and/or marketed products.
Assist in signal generation and safety analysis activities.
Ensure quality of literature searches and reporting.
Review of local/global literature reports to determine regional reportability.
Create/maintain study summary documents.
Assist with narrative writing for periodic/ad hoc submissions.
Assist with ad hoc or routine safety monitoring activities.
OTHER RESPONSIBILITIES:
Following up with sites regarding outstanding queries.
Follow up on reconciliation of discrepancies.
Follow departmental AE workflow procedures
Closure and deletion of cases
Perform any other drug safety related activities as assigned
Perform literature review activities when trained and assigned.

SPECIALIZED KNOWLEDGE AND SKILLS:
Basic competence with medical and therapeutic terminology.
Ability to work independently but guided by documented procedures, with appropriate support.
Able to work effectively as part of a team.
Understanding of patient safety regulatory obligations.
Should be familiar regulatory &pharmacovigilance guidelines.
Should be familiar with pharmacovigilance terminology.
Excellent attention to detail.
Ability to deliver within established timelines.
Fluency in English and excellent comprehension.
Computer literate.

COMMUNICATION SKILLS:
Requires a proactive approach and excellent written/oral communication and interpersonal skills. Strong interpersonal skills required to interact with clients, management, and peers effectively. Effective cross- department communication. Ability to document and communicate problem/resolution and information/action plans.

DESIRED TECHNICAL SKILLS:
Person should be familiar with MS Office Tools.
Safety database knowledge.

OTHER SKILLS:
The ability to contribute to a team environment with a high degree of professionalism and skill. Demonstrate flexibility within a dynamic, fast-paced, cross-functional team. Demonstrated ability to complete multiple tasks concurrently and deliver results in a fast-paced environment. Ability to perform under stringent timelines.

APPLY ONLINE 

Opening for Quality - CDM Cognizant Technology Solutions India Ltd

Cognizant Technology Solutions India Ltd Careers
Minimum of 1 years relevant experience in Clinical data management, Pharmacovigilance or equivalent clinical domain or hands on relevant QC experience. Prior experience in performing QC activities preferred.

APPLY ONLINE 

Sunday, 8 November 2015

Thursday, 5 November 2015

Stable & good career opportunity for bio-science, pharmacy graduates and post graduates















India has become a major hub for clinical trials. Despite this, several problems related to availability of drugs, distribution, accessibility and consumption still remain at large. 

Pharmacovigilance is the discipline which takes care of such aspects and is concerned with identifying, validating, quantifying and evaluating adverse reactions associated with the use of drugs thereby improving the safety of medicines in use. 

Bio-Science, Pharma, Medical & Para Medical Graduates & Post Graduates can enter into these sector a career option. All major CRO, Bio-pharma organization, Medical Device companies, KPO, BPO and IT Life Science companies is on the move of hiring knowledgable anad certified pharmacovigilance candidates.

Now here, any aspirant who wants to join in this industry should focus in two basic issues . The first point is, developing a strong pharmacovigilance knowledge base and the second one is preparing him or herself for interview.

While making a choice of developing knowledge development, as a candidate, you need to do a certificate program in pharmacovigilance. There is no mandetory need of university approved certification or duration of program as a key factory for hiring terms & condition from leading organization, but all the hiring organization typically looks into the quality of knowledge base that a candidate have with them, so that they can use the knowledge to implement into the project management aspects directly.

So, aspirants should focus on individual goal about the learning process and content of the syllabus rather than large amount course fee, brand institutions, good infrastructure and campus etc. The chance of getting jobs after completion of the program is totally depends on the aspirants rather than the institute, institute can help the aspirants by providing best possible knowledge base and maximizing the interviewing opportunity, but the ultimate work is to perform well on the day of interview by the candidate, there is no shortcut.

Current trend is that, while selecting an institute for pharmacovigilance certification much importance are given on the content of the program than anything else. Following are some basic outline of any pharmacovigilance certification program which can help you to get jobs.  It should include like, basic principles of pharmacovigilance and clinical research, regulatory affairs environment FDA, CDSCO, EMA, management of pharmacovigilance data, risk management in pharmacovigilance and pharmacoepidemiology, may more etc. The objective should be to develop candidates who are experts at monitoring the adverse effects of the drugs which have been released in the market. Their goal should be to establish safety of the drug and oversee the well-being of the consumers.

Pharmacovigilance is still in its infancy in India, therefore higher standards of pharmacovigilance are warranted to be at par with the rest of the world in terms of not only compliance to regulations but also to implement quality systems in all pharmaceutical companies especially the generic companies which manufacture bulk drugs that are marketed in India and the Western countries. 

There is no shortage of job opportunities in this field as good pharmacovigilance practice makes for good business sense. Students of this field can get jobs in all leading CRO, Bio-Pharma organization, Medical Device companies, KPO, BPO and IT Life Science companies with attractive salaries with robust increments, world class learning and global exposure.

Pharmacovigilance Certification Program-100% Placement Assistence


Pharmacovigilance Certification Program-Application Form-Apply in the following link:
CLICK HERE-APPLICATION FORM

FDA approves new treatment for HIV


Genvoya Feature Graphic
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.

The CDC estimates that 1.2 million persons ages 13 years and older are living with HIV infection, and that more than another 150,000 persons in this age range have HIV but are unaware of their infection. Over the past decade, the number of people living with HIV has increased, while the annual number of new HIV infections has remained relatively stable.
“Today’s approval of a fixed dose combination containing a new form of tenofovir provides another effective, once daily complete regimen for patients with HIV-1 infection,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research.
Genvoya is approved for use in HIV-infected adults and children ages 12 years and older weighing at least 35 kilograms (77 pounds) who have never taken HIV therapy (treatment-naïve) and HIV-infected adults whose HIV-1 virus is currently suppressed. While Genvoya is not recommended for patients with severe renal impairment, those with moderate renal impairment can take Genvoya.
Genvoya’s safety and efficacy in adults were evaluated in 3,171 participants enrolled in four clinical trials. Depending on the trial, participants were randomly assigned to receive Genvoya or another FDA approved HIV treatment. Results showed Genvoya was effective in reducing viral loads and comparable to the other treatment regimens.

Wednesday, 4 November 2015

Pharmacovigilance in Clinical Practice


Drug safety monitoring is an essential element for the effective use of medicines and for high quality medical care. It has the potential to inspire confidence and trust among patients and health professionals in medicines and contributes to raising standards of medical practice. Pharmacovigilance is a clinical discipline in its own right - one that contributes to an ethos of safety and serves as an indicator of the standards of clinical care practised within a country. Healthcare practitioners are in a position to make good use of their patients’ positive and negative experiences of treatment to contribute to medical science and to an improved understanding of disease and of the medicines.
There are three approaches that might serve to increase awareness and interest in drug safety among clinicians, and to address research issues. These are described in the following sections.

Introduction
Drug safety monitoring is an essential element for the effective use of medicines and for high quality medical care. It has the potential to inspire confidence and trust among patients and health professionals in medicines and contributes to raising standards of medical practice. Pharmacovigilance is a clinical discipline in its own right - one that contributes to an ethos of safety and serves as an indicator of the standards of clinical care practised within a country. Healthcare practitioners are in a position to make good use of their patients’ positive and negative experiences of treatment to contribute to medical science and to an improved understanding of disease and of the medicines.
There are three approaches that might serve to increase awareness and interest in drug safety among clinicians, and to address research issues. These are described in the following sections.
Education, training and access to reliable information
Adverse reactions tend to be viewed, incorrectly, as ‘side effects’ and thus as distractions from patients’ and doctors’ priorities. Learning about the scope and severity of ADRs should start early in professional training. Good safety monitoring encourages healthcare practitioners to take fuller responsibility for the medicines they use. It improves clinical effectiveness and increases the confidence with which they and their patients use medicines.
To achieve something nearer ideal practice more attention needs to be given to training health professionals in diagnosis, management and prevention of ADRs. Not all signals are as specific and dramatic, and readily diagnosed, as were the phocomelia and micromelia caused by thalidomide. Recognition of less obvious adverse effects requires clinical alertness, accurate diagnosis and an understanding of the principles of causality assessment.
Health professionals are more likely to identify and report important ADRs if they have confidence in their ability to diagnose, manage and prevent such reactions. National pharmacovigilance centres and training institutions play a central role in this by encouraging inclusion of the principles and methods of pharmacovigilance and the study of iatrogenic disease at undergraduate and postgraduate levels in schools of medicine, pharmacy and nursing.
Pharmacology curricula should give a higher priority to the study of the safety of medicines. This would lead to an enhanced awareness of the balance between the benefits and harms of medicines. An integrated approach to therapeutic decision-making might be encouraged. Excessive and irrational drug use contributes to adverse reactions. The misuse of medicines is largely caused by the poor quality and inaccessibility of drug information available to practitioners. These problems are worsened by:
• aggressive and inaccurate marketing and advertizing
• uninformed patient use and their demands for the latest medicines
• lack of accurate drug information.

Indicators of inappropriate drug use can be obtained from spontaneous reports of ADRs. Case examples may serve as useful teaching tools for improving the safe use of medicines. In some countries an overwhelming volume of information (as opposed to effective communication of critical information) can serve as a deterrent to rational use.
Medication errors and ADRs are well documented in hospitalized and non-hospitalized patients, and they contribute substantially to morbidity and mortality. They also contribute to the number of hospital admissions and are known to occur in the community setting. Many are predictable and preventable.
This suggests considerable opportunity for minimizing the risks of ADRs through rational use, monitoring and follow-up. Early detection is important, particularly in hospitals where systems for detecting ADRs and medication errors will save lives and money. Such systems might be linked to institutional, regional or national pharmacy and therapeutics committees so that information can be used to educate professional staff in safe drug use.
Prospective hospital-based surveillance reduces the risk and severity of ADRs. There is, furthermore, a need to provide health professionals with the skills required to evaluate drug information critically and to decide how the safety profile of a drug (e.g. developed from population data) might be applied to a particular patient. Often, the manufacturer’s product information and promotional materials are the only information available to the practitioner. Evidence-based and comprehensive sources may not be available. Availability of balanced and reliable drug information is likely to improve standards of use and to reduce the frequency of adverse reactions. Information that includes patients’ subjective experiences of adverse reactions would be most useful to patients and to prescribers of medicines. Product safety information, the way it is currently presented, often consists of lists of adverse reactions, perhaps rated in order of frequency, without real description of how these might affect quality of life. Moreover, prescribers should be free to practise without being subjected to the vested interest of manufacturers and any conflict in interest.

Tuesday, 3 November 2015

Pharmacovigilance Industry -Salary-Earning Opportunity

Pharmacovigilance industry is providing good earning opportunity to all the professionals relevant to experience, qualification.

Monday, 2 November 2015

Clinical Research Coordinator -AstraZeneca India Pvt. Ltd-Bengaluru/Bangalore

    ASTRAZENECA PHARMA INDIA is looking for Fresh B.PHARMA candidates for CTA/ CRC role to be based at Bangalore. Only Female candidates are eligible for the role. 

    Here is the brief description of job profile.

    Preparing and submitting study documents to sites
    Coordinating with various vendors for translation and archival of study related documents
    Updating various systems for study milestones
    Preparing study files
    Maintaining trial master files
    Following up with the sites for essential documents
    QC of essential documents

    Candidate needs to have fantastic command over written and spoken English. Good IT skill particularly good knowledge of work, power point, and excel. Understanding of drug development knowledge and knowledge of pharmacology. Requisite qualification is BPharm.

Recruiter Name:Usha Bhatt
Email Address:
Telephone:09902577714

Tumorigenesis: it takes a village

Deficiencies of xenograft assays using homogeneous cell populations or single cells.
Although it is widely accepted that most cancers exhibit some degree of intratumour heterogeneity, we are far from understanding the dynamics that operate among subpopulations within tumours. There is growing evidence that cancer cells behave as communities, and increasing attention is now being directed towards the cooperative behaviour of subclones that can influence disease progression. As expected, these interactions can add a greater layer of complexity to therapeutic interventions in heterogeneous tumours, often leading to a poor prognosis. In this Review, we highlight studies that demonstrate such interactions in cancer and postulate ways to overcome them with better-designed therapeutic strategies.
Read More

Combination cancer immunotherapy and new immunomodulatory targets

Tumours can express co-inhibitory and co-stimulatory ligands.
Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumour response. Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumour regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumour benefit. Numerous additional immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumour microenvironment are potential targets for synergizing with immune checkpoint blockade. Given the breadth of potential targets in the immune system, critical questions to address include which combinations should move forward in development and which patients will benefit from these treatments. This Review discusses the leading drug targets that are expressed on tumour cells and in the tumour microenvironment that allow enhancement of the antitumour immune response.
Read More

Thursday, 29 October 2015

Officer / Executive - Regulatory Affairs ( API )-Sun Pharmaceutical Industries Ltd


 
Job Description
1. Preparation & Compilation of DMF for emerging markets (countries in region of CIS/Asia, Middle east/N. Africa/S.Africa & LATAM) in coordination with plant regulatory affairs.

2.Review and compilation of all the documents received from plant, R&D and other departments as per regulatory requirement

3.Preparation of anticipated queries based on compilation and current query trend.

4. Review and response to the deficiencies received from regulatory authorities/Customers.


APPLY ONLINE

Opening for Rave Programmer Candidates (2-6 yrs) Quintiles 2 - 6 yrs Bengaluru/Bangalore

Quintiles Careers

Dear Candidates,

Looking for experienced candidates in Rave Programming with 2 to 6 years of experience.

RESPONSIBILITIES :-
Development of eCRF to meet the needs of the customer and the clinical trial utilizing protocol and specifications provided at the pre-design meeting. Understand Quintiles EDC processes and the requirements on the design for reporting and study management.
Interprets the study protocol.
Advise and provide justification for design decisions to Principal Programmer and at multiple Design Meetings.
Responsible for optimal design reducing the number of edit checks required, ensuring good system performance, and the utilization of global/client specific libraries to ensure consistency and efficiency.
Facilitates the Internal Edit Check Specification Review Meeting and leads the discussions regarding the Edit Specifications document.
Requires good communication skills and this role will work closely with the Study DTL, Validation team lead (VTL) and Principal Programmer.
Requires a technically logical thinker to resolve questions and issues with the Principal Programmer, DTL and VTL. This role will need to have a good knowledge of forms design, data flow, and the impact of design on the system.
Presentation and negotiation skills with internal and external customers.
Communicates any project risks to the DTL, including the potential for missing a timeline in the Data Management Project Plan
Ensures the completion and documentation of all project-specific training, as well as staying current with required SOP reading
Reviews build timelines and provide inputs.
Reviews budget for own projects, identify out of scope activities if any and inform relevant parties.
Take part in post production change requests.
Understand and implement new tools and technologies of the EDC vendor (preferably Medidata).

APPLY ONLINE

Urgently Required- Pharmacist - Fresher most Welcome- Bengaluru/Bangalore , Mumbai , Pune

2,75,000 - 7,50,000 P.A. + TA , DA +HRA + Conveyance

Completes pharmacy operational requirements by organizing and directing technicians' work flow; verifying their preparation and labeling of pharmaceuticals; verifying order entries, charges, and inspections.  


We are urgently hiring the Male & Female Fresher candidate .Immediately Send your resume to our company email address - career@accentureconsultancy.com

APPLY ONLINE

Wednesday, 28 October 2015

Start your Pharmacovigilance Career- A stable and promising Career


Pharmacovigilance the drug safety it can be defined as the study and prevention of adverse effects caused by pharmaceutical products. Pharmacovigilance is the reason that many drugs are withdrawn from or not even brought into the market at times.
Our national health policy supports and helps to create more awareness about pharmacovigilance as their primary goal is to ensure students of medicine are aware of the adverse effects of certain pharmaceuticals. Pharmacovigilance makes it possible to implement quality systems in all pharmaceutical companies that manufacture large amounts of medicine.

Pharmacovigilance Courses

Training in pharmacovigilance is done by an expert international and national faculty with years of experience in the practical and theoretical aspects. All the study materials and course content are developed in a way that helps students to get the quality knowledge, exactly what is required to work into the industry as well as to prepare well for interview.

You may be eligible for a course in pharmacovigilance, if you are any one of the following:
  • Graduate in Pharmacy and Bio-Sciences (final year students are also eligible)
  • Medical Professional i.e Doctor of all disciplines
  • Graduate in pharmacy and bio-sciences
  • Junior professional in Pharmaceutical industry, IT Industry and Clinical Research Organisations.

Pharmacovigilance Salary

A job holder in this field can easily get the starting salary of Rs.3.5 - Rs.8 lakhs P.A..As more recognition is given to drug safety all over the world,jobs in India in this field are increasing in number. Hiring process are very much selective to candidates educational qualification, back ground knowledge, knowledge over drug development / pharmacovigilance area, communication skill and experience as applicable for different positions.

Pharmacovigilance Job Prospects

There is no shortage of jobs in this field as high-quality pharmacovigilance practice makes for good business dealing. Students in this field can get jobs in various pharmaceutical companies, bio-tech companies, medical device and IT Life Science KPO & BPO,Clinical Research Organisations (CRO), can earn attractive and handsome packages.With new drugs being made every day, a career in pharmacovigilance has promising prospects.

Pharmacovigilance Eligibility Criteria

To pursue a career in pharmacovigilance, the minimum eligibility criteria to apply for the program is:
  • A postgraduate or graduate degree in Bio Science/Life Sciences (with any of the following subjects: Botany, Zoology, Biochemistry, Microbiology, Genetics, Biotech)
  • A postgraduate or graduate degree with Chemistry as a subject
  • A postgraduate or graduate degree in Pharmacy or Pharmaceutical Sciences, PharmD
  • A postgraduate or graduate degree in Medicine
The selection process is based on merit.

Pharmacovigilance Scholarships

This program offers scholarship to every students based on merit. The Scholarship is offered based on the overall performance of the students from 10th level to last educational qualification examination (% of marks).

Pharmacovigilance Duration & Venue

The course takes student admission twice in a month . The first batch intake starts from 1st-10th of a month and second batch starts from 15-20th of a month.The number of admissions to each batch is limited, so that personal attention can be paid to each student, and this will also facilitate effective discussions and project oriented training during the course of study. Students and working professionals can do the program program from anywhere. Classes are in e-learning mode, where lectures will be provided over online environment in flexible timings (7-9am, 3-5pm and 8-10pm). Students can schedule their class day and time wise. Effective days of training are taken on the basis of no. of class.

Pharmacovigilance Fees

The total fees for 2 to 6 month course will be Rs.7,000 to 20,000 for working Indian Professionals and SAARC countries. The fees will cover all course materials, tution and examination fees.

Pharmacovigilance Examination

At the end of program students will be assessed on how well they have understood the course material. The exams will consist of:
  • e-Exams written section consisting of multiple choice and semi-long question
  • A Viva: 30 minutes long
  • A short project to be submitted at the end of the course on the topics to be given by the Faculty on Pharmacovigilance
MORE ABOUT THE PROGRAM, FEES, DURATION and PLACEMENT ASSISTANCE.
APPLY THE PROGRAM HERE

Clinical Trials -What is that?




Photograph of test tubes in a tray
Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose, or treat a disease. Clinical trials may also compare a new treatment to a treatment that is already available.
Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. Each study has its own rules about who can take part. Some studies need volunteers with a certain disease. Some need healthy people. Others want just men or just women.
An Institutional Review Board (IRB) reviews, monitors, and approves many clinical trials. It is an independent committee of physicians, statisticians, and members of the community. Its role is to
  • Make sure that the study is ethical
  • Protect the rights and welfare of the participants
  • Make sure that the risks are reasonable when compared to the potential benefits
Read More

Drug Safety Physician / Medical Reviewer - Synowledge PV Services India Pvt Ltd

Synowledge PV Services India Pvt Ltd Careers
JOB TITLE: Drug Safety Physician/ Senior Drug Safety Physician

LOCATION: Mysore, India

YEARS OF EXPERIENCE: 0-5 years experience in PV

EDUCATION: MBBS/ MD (Any)

ESSENTIAL DUTIES AND RESPONSIBILITIES: 

As a Medical Reviewer

Conduct review and assessment of individual case safety reports obtained from clinical trials, spontaneous and solicited reports
Determine regulatory reportability of cases obtained from clinical trials, spontaneous and solicited reports within assigned therapeutic team and across all products/sites, as necessary, and in a timely fashion
Determine seriousness and relatedness across products as assigned
Review and verify appropriate selection of adverse events from source documents, assign appropriate MedDRA code, assess labeling, review narrative.
Acquire and maintain current knowledge of product portfolio and safety profiles for products across therapeutic areas
Escalate complex case issues on client product(s) to the medical review team of the client as appropriate
Identify and resolve case issues, coordinate with client therapeutic teams/site for specific products or functional groups
Communicate and interact effectively within and across all client therapeutic teams, and within functional team management as appropriate
Acquire and maintain knowledge of applicable Global Health Authority regulations
Perform any other drug safety related activities as assigned
Participate in internal and external audits and inspections by clients and health authorities
APPLY ONLINE

Openings for Freshers- Pharmacovigilance

Quintiles Careers
Dear Candidate,

Looking for freshers who has completed their graduation B.Pharma/M.Pharma/ BDS/ M.Sc/B.Tech.

Quintiles is the worlds leading provider of biopharmaceutical services. With a network of 29,000 employees conducting business in approximately 100 countries, Quintiles has helped develop or commercialize all of 2013s top 100 best-selling products or compounds. Using our extensive therapeutic, scientific and analytics expertise, we help biopharmaceutical and health sciences customers navigate the increasingly complex landscape with more predictability to enable better outcomes.

RESPONSIBILITIES
Provide intake and tracking of initial safety and clinical event validation and adjudication (CEVA) data. Transfer incoming
safety/CEVA data to project team. Identify any problems with incoming faxes and bring them to the attention of the senior
team member.
Distribute safety data to marketing authorization holders, customers, regulators and investigators.
Specific project responsibilities include set-up and/or maintenance of safety/CEVA files for reported events; archiving of
files when closed; coordination of transfer of archived material to company/customer archive storage facilities;
preparation and assistance in setting-up and updating project files; maintenance of personal safety files for mail merges
and regulatory documents; where required, data entry of events into tracking database and assistance of transfer of
events to customers.
Provide administrative support for the department by coordinating team/department/customer meetings, coordinating
stationery orders, dispatching data via courier services, reserving meeting rooms and IT equipment; and providing
secretarial support as required.
Generate and distribute alert letters.
Identify and record quality problems and bring them to the attention of a senior team member.
Provide training/mentoring new/less experienced staff.
Assist project lead and CEVA management with specific aspects of CEVA processes.
Set up and maintain Serious Adverse Event (SAE) files for reported events; organize and send files for archive when
events are closed.
Coordinate, schedule and submit reports to regulatory authorities in accordance with deadlines.
Coordinate distribution of safety letters to study investigators and Clinical Research Associates.
Assist in processing incoming and outgoing Adverse Event (AE) reports by collecting and tracking incoming AE reports
sent via fax, email, eCRF, etc; determining initial/update status of incoming events; tracking timelines for completion of
AE processing; performing data entry into safety database; routing report information to appropriate PhV project
personnel in the workflow for continued processing; performing quality control activities as directed by project lead or
manager; generating established safety data reports; submitting AE reports to client and other project team members
identified by project lead; obtaining confirmation of report receipt and track submission; and assuming workflow
responsibilities for local and global projects.
Perform records management tasks such as creating and tracking case folders for AE reports; filing, retrieving and
delivering case folders; assisting in maintenance of document control room and relevant applications/systems as directed
by manager; archiving case folders and project files; assisting in creation of PhV records management processes and
procedures; providing key input to management on acquisition and/or upgrade of records management
application/systems; and serving as liaison between Pharmacovigilance department and records management
department.
Assist with system support tasks such as utilizing design specifications, AE form, and protocol, creating projectspecific
entry specifications and annotated AE forms for safety database with direction from project lead and/or manager;
creating project tracking spreadsheets and associated tracking entry specifications; assisting in database validation
through performance of user testing; performing ad hoc database searches for project team leads; assisting project lead
in assessing database setup needs; and assisting with assuring systems issues are reported and resolved.
Perform additional project-related and administrative tasks such as handling investigator mailings including creation of
labels using investigator list, copying of documents, envelope stuffing, and tracking and filing of submitted materials;
creating and maintain project files; working with project lead to develop project instructions; performing reconciliation
between the safety and clinical databases; distributing AE listings to client and/or project team members; performing
project start-up tasks; providing project metrics to management; and assisting with data entry, workflow and deadline
quality measurements.
Participate in continuous improvement of all departmental processes and procedures.
All responsibilities are essential job functions unless noted as nonessential (N).
REQUIRED KNOWLEDGE, SKILLS AND ABILITIES
Basic knowledge of ICH and GCP
Basic knowledge of medical terminology if processing
Good understanding of Core Operating Procedures (COPs)
Word processing and data entry skills
Strong organizational skills and time management skills
Flexibility and excellent verbal and written communication skills
Ability to deal successfully with many internal clients competing for attention, services and resources
Good attention to detail and accuracy
Ability to establish and maintain effective working relationships with co-workers, managers and colleagues.
Highly motivated and organised with a flexible attitude
Ability to follow instructions/guidelines, utilize initiative and work independently
Ability to establish and maintain effective working relationships with coworkers, managers and clients

Regards,

Kavya